Skip to main content

Table 1 Patient and disease characteristics

From: Aggressive fibromatosis response to tamoxifen: lack of correlation between MRI and symptomatic response

 

#

(%)

[range]

Number of patients

32

  

 Male

14

(40%)

 

 Female

19

(60%)

 

Median age on starting tamoxifen

41

 

[19–68]

Site of origin

   

 Extremities (including girdle)

18

(56%)

 

 Chest wall

5

(15%)

 

 Pelvis

3

(10%)

 

 Abdominal wall

3

(10%)

 

 Paravertebral

1

(3%)

 

 Head and neck

2

(6%)

 

Sporadic disease

31

(97%)

 

FAP-associated

1

(3%)

 

Previous treatments

18

(56%)

 

 Local treatment

  Surgery

10

(31%)

 

  Surgery and RT

7

(21%)

 

  RT alone

0

  

 Systemic treatment

4

(12%)

 

No previous treatment

14

(44%)

Â